Skip to main content
Top
Published in: Cardiology and Therapy 2/2020

Open Access 01-12-2020 | Heart Failure | Original Research

A Qualitative Analysis of Patient-Related Factors Associated With Implantable Cardioverter Defibrillator Acceptance

Authors: Amber E. Johnson, Yamira K. Bell, Megan E. Hamm, Samir F. Saba, Larissa Myaskovsky

Published in: Cardiology and Therapy | Issue 2/2020

Login to get access

Abstract

Introduction

Patient-related factors determining implantable cardioverter-defibrillator (ICD) use for primary prevention of sudden cardiac death in patients with cardiomyopathy have not been well explored. To assess race and sex differences regarding ICD preferences in this patient population, we sought to analyze a diverse cohort of patients with heart failure (HF) with reduced ejection fraction.

Methods

We conducted qualitative interviews of 28 adults with severe HF and either (1) an ICD or (2) no ICD. Interviews were recorded, transcribed, and coded using an inductively developed codebook by independent investigators. Coding was fully adjudicated and transcripts were reviewed to identify themes.

Results

We recruited patients between 12/2015 and 06/2017, primarily from the outpatient cardiology clinic (24/28 = 86%). Half were women (50%) and 13/28 (46%) were black. Eight did not have an ICD. Neither race nor sex was associated with ICD. Four themes emerged: (1) HF requiring an ICD is profoundly disruptive to patients’ lives; (2) patients had positive, yet unrealistic opinions of ICDs; or (3) Patients had negative/ambivalent opinions of ICDs; (4) medical decision-making included aspects of shared decision-making and informed consent.

Conclusions

Patients without ICDs perceived less benefit from ICDs and had less decision support. Participants viewed conversations with providers as insufficient. Needed interventions include the development and validation of processes for informed decisions about ICDs.
Appendix
Available only for authorised users
Literature
2.
go back to reference Zheng ZJ, Croft JB, Giles WH, Mensah GA. Sudden cardiac death in the United States, 1989 to 1998. Circulation. 2001;104(18):2158–63.PubMedCrossRef Zheng ZJ, Croft JB, Giles WH, Mensah GA. Sudden cardiac death in the United States, 1989 to 1998. Circulation. 2001;104(18):2158–63.PubMedCrossRef
3.
go back to reference Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, et al. Executive summary: heart disease and stroke statistics—2016 update: a report from the American Heart Association. Circulation. 2016;133(4):447–54.PubMedCrossRef Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, et al. Executive summary: heart disease and stroke statistics—2016 update: a report from the American Heart Association. Circulation. 2016;133(4):447–54.PubMedCrossRef
4.
go back to reference Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H, et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med. 1996;335(26):1933–40.PubMedCrossRef Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H, et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med. 1996;335(26):1933–40.PubMedCrossRef
5.
go back to reference Kadish A, Dyer A, Daubert JP, Quigg R, Estes NA, Anderson KP, et al. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med. 2004;350(21):2151–8.PubMedCrossRef Kadish A, Dyer A, Daubert JP, Quigg R, Estes NA, Anderson KP, et al. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med. 2004;350(21):2151–8.PubMedCrossRef
6.
go back to reference Lakshmanadoss U, Sherazi S, Aggarwal A, Hsi D, Aktas MK, Daubert JP, et al. Underutilization of implantable cardioverter defibrillator in primary prevention of sudden cardiac arrest. Cardiol Res. 2011;2(1):1–6.PubMedPubMedCentral Lakshmanadoss U, Sherazi S, Aggarwal A, Hsi D, Aktas MK, Daubert JP, et al. Underutilization of implantable cardioverter defibrillator in primary prevention of sudden cardiac arrest. Cardiol Res. 2011;2(1):1–6.PubMedPubMedCentral
7.
go back to reference Hernandez AF, Fonarow GC, Liang L, Al-Khatib SM, Curtis LH, LaBresh KA, et al. Sex and racial differences in the use of implantable cardioverter-defibrillators among patients hospitalized with heart failure. JAMA. 2007;298(13):1525–32.PubMedCrossRef Hernandez AF, Fonarow GC, Liang L, Al-Khatib SM, Curtis LH, LaBresh KA, et al. Sex and racial differences in the use of implantable cardioverter-defibrillators among patients hospitalized with heart failure. JAMA. 2007;298(13):1525–32.PubMedCrossRef
8.
go back to reference Hess PL, Hernandez AF, Bhatt DL, Hellkamp AS, Yancy CW, Schwamm LH, et al. Sex and race/ethnicity differences in implantable cardioverter-defibrillator counseling and use among patients hospitalized with heart failure: findings from the get with the guidelines-heart failure program. Circulation. 2016;134(7):517–26.PubMedCrossRef Hess PL, Hernandez AF, Bhatt DL, Hellkamp AS, Yancy CW, Schwamm LH, et al. Sex and race/ethnicity differences in implantable cardioverter-defibrillator counseling and use among patients hospitalized with heart failure: findings from the get with the guidelines-heart failure program. Circulation. 2016;134(7):517–26.PubMedCrossRef
9.
go back to reference Bank AJ, Gage RM, Olshansky B. On the underutilization of cardiac resynchronization therapy. J Cardiac Fail. 2014;20(9):696–705.CrossRef Bank AJ, Gage RM, Olshansky B. On the underutilization of cardiac resynchronization therapy. J Cardiac Fail. 2014;20(9):696–705.CrossRef
10.
go back to reference Zhang L, Narayanan K, Chugh H, Shiota T, Zheng ZJ, Chugh SS. Factors influencing utilization of the primary prevention implantable defibrillator. PLoS ONE. 2015;10(3):e0121515.PubMedPubMedCentralCrossRef Zhang L, Narayanan K, Chugh H, Shiota T, Zheng ZJ, Chugh SS. Factors influencing utilization of the primary prevention implantable defibrillator. PLoS ONE. 2015;10(3):e0121515.PubMedPubMedCentralCrossRef
11.
go back to reference Pokorney SD, Miller AL, Chen AY, Thomas L, Fonarow GC, de Lemos JA, et al. Reassessment of cardiac function and implantable cardioverter-defibrillator use among Medicare patients with low ejection fraction after myocardial infarction. Circulation. 2017;135(1):38–47.PubMedCrossRef Pokorney SD, Miller AL, Chen AY, Thomas L, Fonarow GC, de Lemos JA, et al. Reassessment of cardiac function and implantable cardioverter-defibrillator use among Medicare patients with low ejection fraction after myocardial infarction. Circulation. 2017;135(1):38–47.PubMedCrossRef
12.
go back to reference Patel NJ, Edla S, Deshmukh A, Nalluri N, Patel N, Agnihotri K, et al. Gender, racial, and health insurance differences in the trend of implantable cardioverter-defibrillator (ICD) utilization: a United States experience over the last decade. Clin Cardiol. 2016;39(2):63–71.PubMedPubMedCentralCrossRef Patel NJ, Edla S, Deshmukh A, Nalluri N, Patel N, Agnihotri K, et al. Gender, racial, and health insurance differences in the trend of implantable cardioverter-defibrillator (ICD) utilization: a United States experience over the last decade. Clin Cardiol. 2016;39(2):63–71.PubMedPubMedCentralCrossRef
13.
go back to reference Al-Khatib SM, Hellkamp AS, Hernandez AF, Fonarow GC, Thomas KL, Al-Khalidi HR, et al. Trends in use of implantable cardioverter-defibrillator therapy among patients hospitalized for heart failure: have the previously observed sex and racial disparities changed over time? Circulation. 2012;125(9):1094–101.PubMedPubMedCentralCrossRef Al-Khatib SM, Hellkamp AS, Hernandez AF, Fonarow GC, Thomas KL, Al-Khalidi HR, et al. Trends in use of implantable cardioverter-defibrillator therapy among patients hospitalized for heart failure: have the previously observed sex and racial disparities changed over time? Circulation. 2012;125(9):1094–101.PubMedPubMedCentralCrossRef
14.
go back to reference Randolph TC, Hellkamp AS, Zeitler EP, Fonarow GC, Hernandez AF, Thomas KL, et al. Utilization of cardiac resynchronization therapy in eligible patients hospitalized for heart failure and its association with patient outcomes. Am Heart J. 2017;189:48–58.PubMedCrossRef Randolph TC, Hellkamp AS, Zeitler EP, Fonarow GC, Hernandez AF, Thomas KL, et al. Utilization of cardiac resynchronization therapy in eligible patients hospitalized for heart failure and its association with patient outcomes. Am Heart J. 2017;189:48–58.PubMedCrossRef
15.
go back to reference Mezu U, Ch I, Halder I, London B, Saba S. Women and minorities are less likely to receive an implantable cardioverter defibrillator for primary prevention of sudden cardiac death. Europace. 2012;14(3):341–4.PubMedCrossRef Mezu U, Ch I, Halder I, London B, Saba S. Women and minorities are less likely to receive an implantable cardioverter defibrillator for primary prevention of sudden cardiac death. Europace. 2012;14(3):341–4.PubMedCrossRef
16.
go back to reference Johnson AE, Adhikari S, Althouse AD, Thoma F, Marroquin OC, Koscumb S, et al. Persistent sex disparities in implantable cardioverter-defibrillator therapy. Pacing Clin Electrophysiol. 2018;41(9):1150–7.PubMedCrossRef Johnson AE, Adhikari S, Althouse AD, Thoma F, Marroquin OC, Koscumb S, et al. Persistent sex disparities in implantable cardioverter-defibrillator therapy. Pacing Clin Electrophysiol. 2018;41(9):1150–7.PubMedCrossRef
17.
go back to reference Al-Khatib SM, Stevenson WG, Ackerman MJ, Bryant WJ, Callans DJ, Curtis AB, et al. 2017 AHA/ACC/HRS Guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: executive summary: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines and the heart rhythm society. Circulation. 2018;138(13):e210–71.PubMed Al-Khatib SM, Stevenson WG, Ackerman MJ, Bryant WJ, Callans DJ, Curtis AB, et al. 2017 AHA/ACC/HRS Guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: executive summary: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines and the heart rhythm society. Circulation. 2018;138(13):e210–71.PubMed
18.
go back to reference Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Drazner MH, et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation. 2013;128(16):e240–327.PubMed Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Drazner MH, et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation. 2013;128(16):e240–327.PubMed
19.
go back to reference Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016;37(27):2129–200.PubMedCrossRef Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016;37(27):2129–200.PubMedCrossRef
20.
go back to reference Kilbourne AMSG, Hyman K, Crowley-Matoka M, Fine MJ. Advancing health disparities research within the health care system: a conceptual framework. Am J Public Health. 2006;96(12):2113–211.PubMedPubMedCentralCrossRef Kilbourne AMSG, Hyman K, Crowley-Matoka M, Fine MJ. Advancing health disparities research within the health care system: a conceptual framework. Am J Public Health. 2006;96(12):2113–211.PubMedPubMedCentralCrossRef
21.
go back to reference Ang DC, Monahan PO, Cronan TA. Understanding ethnic disparities in the use of total joint arthroplasty: application of the health belief model. Arthritis Rheum. 2008;59(1):102–8.PubMedCrossRef Ang DC, Monahan PO, Cronan TA. Understanding ethnic disparities in the use of total joint arthroplasty: application of the health belief model. Arthritis Rheum. 2008;59(1):102–8.PubMedCrossRef
22.
go back to reference Green AR, Jenkins A, Masoudi FA, Magid DJ, Kutner JS, Leff B, et al. Decision-making experiences of patients with implantable cardioverter defibrillators. Pacing Clin Electrophysiol. 2016;39(10):1061–9.PubMedPubMedCentralCrossRef Green AR, Jenkins A, Masoudi FA, Magid DJ, Kutner JS, Leff B, et al. Decision-making experiences of patients with implantable cardioverter defibrillators. Pacing Clin Electrophysiol. 2016;39(10):1061–9.PubMedPubMedCentralCrossRef
23.
go back to reference Lewis KB, Stacey D, Matlock DD. Making decisions about implantable cardioverter-defibrillators from implantation to end of life: an integrative review of patients' perspectives. The patient. 2014;7(3):243–60.PubMedCrossRef Lewis KB, Stacey D, Matlock DD. Making decisions about implantable cardioverter-defibrillators from implantation to end of life: an integrative review of patients' perspectives. The patient. 2014;7(3):243–60.PubMedCrossRef
24.
go back to reference Myaskovsky LFL. Understanding racial differences in preference for cadaveric versus living donor kidney transplantation. Pittsburgh, PA: Center for Health Equity Research and Promotion (CHERP), VA Pittsburgh Healthcare System (VAPHS). 2005. Myaskovsky LFL. Understanding racial differences in preference for cadaveric versus living donor kidney transplantation. Pittsburgh, PA: Center for Health Equity Research and Promotion (CHERP), VA Pittsburgh Healthcare System (VAPHS). 2005.
25.
go back to reference Kuzel. Sampling in qualitative inquiry. In: Crabtree BMW (ed) Doing qualitative research. 3. Newbury Park, CA: Sage; 1982. Kuzel. Sampling in qualitative inquiry. In: Crabtree BMW (ed) Doing qualitative research. 3. Newbury Park, CA: Sage; 1982.
27.
go back to reference Allen LA, Stevenson LW, Grady KL, Goldstein NE, Matlock DD, Arnold RM, et al. Decision making in advanced heart failure: a scientific statement from the American Heart Association. Circulation. 2012;125(15):1928–52.PubMedPubMedCentralCrossRef Allen LA, Stevenson LW, Grady KL, Goldstein NE, Matlock DD, Arnold RM, et al. Decision making in advanced heart failure: a scientific statement from the American Heart Association. Circulation. 2012;125(15):1928–52.PubMedPubMedCentralCrossRef
28.
go back to reference Matlock DD, Nowels CT, Masoudi FA, Sauer WH, Bekelman DB, Main DS, et al. Patient and cardiologist perceptions on decision making for implantable cardioverter-defibrillators: a qualitative study. Pacing Clin Electrophysiol. 2011;34(12):1634–44.PubMedCrossRef Matlock DD, Nowels CT, Masoudi FA, Sauer WH, Bekelman DB, Main DS, et al. Patient and cardiologist perceptions on decision making for implantable cardioverter-defibrillators: a qualitative study. Pacing Clin Electrophysiol. 2011;34(12):1634–44.PubMedCrossRef
29.
go back to reference Ottenberg AL, Mueller PS, Topazian RJ, Kaufman S, Swetz KM. "It's not broke, so let's not try to fix it": why patients decline a cardiovascular implantable electronic device. Pacing Clin Electrophysiol. 2014;37(10):1306–14.PubMedPubMedCentralCrossRef Ottenberg AL, Mueller PS, Topazian RJ, Kaufman S, Swetz KM. "It's not broke, so let's not try to fix it": why patients decline a cardiovascular implantable electronic device. Pacing Clin Electrophysiol. 2014;37(10):1306–14.PubMedPubMedCentralCrossRef
30.
go back to reference Balci KG, Balci MM, Akboga MK, Sen F, Acar B, Yilmaz S, et al. Perceived benefits of implantable cardioverter defibrillator implantation among heart failure patients and its relation to quality of life: a cross-sectional study. Cardiol Therapy. 2015;4(2):155–65.CrossRef Balci KG, Balci MM, Akboga MK, Sen F, Acar B, Yilmaz S, et al. Perceived benefits of implantable cardioverter defibrillator implantation among heart failure patients and its relation to quality of life: a cross-sectional study. Cardiol Therapy. 2015;4(2):155–65.CrossRef
31.
go back to reference Matlock DD, Jones J, Nowels CT, Jenkins A, Allen LA, Kutner JS. Evidence of cognitive bias in decision making around implantable-cardioverter defibrillators: a qualitative framework analysis. J Cardiac Fail. 2017;23(11):794–9.CrossRef Matlock DD, Jones J, Nowels CT, Jenkins A, Allen LA, Kutner JS. Evidence of cognitive bias in decision making around implantable-cardioverter defibrillators: a qualitative framework analysis. J Cardiac Fail. 2017;23(11):794–9.CrossRef
32.
go back to reference Stewart GC, Weintraub JR, Pratibhu PP, Semigran MJ, Camuso JM, Brooks K, et al. Patient expectations from implantable defibrillators to prevent death in heart failure. J Cardiac Fail. 2010;16(2):106–13.CrossRef Stewart GC, Weintraub JR, Pratibhu PP, Semigran MJ, Camuso JM, Brooks K, et al. Patient expectations from implantable defibrillators to prevent death in heart failure. J Cardiac Fail. 2010;16(2):106–13.CrossRef
33.
go back to reference Hauptman PJ, Chibnall JT, Guild C, Armbrecht ES. Patient perceptions, physician communication, and the implantable cardioverter-defibrillator. JAMA Internal Med. 2013;173(7):571–7.CrossRef Hauptman PJ, Chibnall JT, Guild C, Armbrecht ES. Patient perceptions, physician communication, and the implantable cardioverter-defibrillator. JAMA Internal Med. 2013;173(7):571–7.CrossRef
34.
go back to reference Zeuner R, Frosch DL, Kuzemchak MD, Politi MC. Physicians' perceptions of shared decision-making behaviours: a qualitative study demonstrating the continued chasm between aspirations and clinical practice. Health Expect. 2015;18(6):2465–76.PubMedCrossRef Zeuner R, Frosch DL, Kuzemchak MD, Politi MC. Physicians' perceptions of shared decision-making behaviours: a qualitative study demonstrating the continued chasm between aspirations and clinical practice. Health Expect. 2015;18(6):2465–76.PubMedCrossRef
35.
go back to reference Lin GA, Matlock DD. Less patient-centered care: an unintended consequence of guidelines? JAMA Internal Med. 2013;173(7):578–9.CrossRef Lin GA, Matlock DD. Less patient-centered care: an unintended consequence of guidelines? JAMA Internal Med. 2013;173(7):578–9.CrossRef
36.
go back to reference Bonow RO, Ganiats TG, Beam CT, Blake K, Casey DE Jr, Goodlin SJ, et al. ACCF/AHA/AMA-PCPI 2011 performance measures for adults with heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures and the American Medical Association-Physician Consortium for Performance Improvement. Circulation. 2012;125(19):2382–401.PubMedCrossRef Bonow RO, Ganiats TG, Beam CT, Blake K, Casey DE Jr, Goodlin SJ, et al. ACCF/AHA/AMA-PCPI 2011 performance measures for adults with heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures and the American Medical Association-Physician Consortium for Performance Improvement. Circulation. 2012;125(19):2382–401.PubMedCrossRef
Metadata
Title
A Qualitative Analysis of Patient-Related Factors Associated With Implantable Cardioverter Defibrillator Acceptance
Authors
Amber E. Johnson
Yamira K. Bell
Megan E. Hamm
Samir F. Saba
Larissa Myaskovsky
Publication date
01-12-2020
Publisher
Springer Healthcare
Published in
Cardiology and Therapy / Issue 2/2020
Print ISSN: 2193-8261
Electronic ISSN: 2193-6544
DOI
https://doi.org/10.1007/s40119-020-00180-9

Other articles of this Issue 2/2020

Cardiology and Therapy 2/2020 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.